OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response

August 16, 2024

OncoHost announces three abstracts selected for presentation at WCLC 2024

August 5, 2024

Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

August 2, 2024

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

July 30, 2024

Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection

July 29, 2024

New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients

June 18, 2024

OncoHost: Finding New, Better Immunotherapies for Complex Cancers